Primary systemic mycosis is a serious fungal infection that affects the body beyond the skin and often starts in the lungs. People with primary systemic mycosis may have fever, cough, tiredness, weight loss, or chest pain, and early symptoms of primary systemic mycosis can look like other common illnesses. It can affect healthy people after breathing in fungal spores, but severe illness is more likely in infants, older adults, pregnant people, and those with weakened immune systems. Not everyone will have the same experience, but primary systemic mycosis may last weeks to months and can become life threatening if it spreads to organs such as the brain. Treatment usually involves antifungal medicine, and some people need care in the hospital.
How many people live with Primary systemic mycosis?
Primary systemic mycosis is not one single illness but a group of serious fungal infections, so there is no widely accepted one-number estimate for how many people are living with it worldwide or in the United States. Major public health sources, including the CDC and WHO, report numbers for the individual infections in this group rather than for "primary systemic mycosis" as a whole, so global and U.S. totals are not consistently reported by a single authoritative source.
Overview
Primary systemic mycosisSymptoms
Primary systemic mycosis often starts with fever, cough, chest pain, and tiredness. Many living with primary systemic mycosis may also have weight loss, shortness of breath, or night sweats, though symptoms can vary with the infection and the organs involved.
Outlook and prognosis
Primary systemic mycosis can be serious, but many people improve with prompt antifungal treatment and close follow-up. Outlook depends on the fungus involved, how early treatment starts, and whether the infection has spread or the immune system is weakened.
Causes and risk factors
Primary systemic mycosis usually follows breathing in fungal spores from soil or dust. Risk is higher with weakened immunity, heavy environmental exposure, and sometimes certain jobs or outdoor activities. Age, pregnancy, and some long-term medicines can also raise risk.
Genetic influences
Genetics usually play only a small part in primary systemic mycosis. Some inherited immune-system differences may raise susceptibility or affect how severe primary systemic mycosis becomes, but exposure and overall immune health are usually more important.
Diagnosis
Primary systemic mycosis is diagnosed using your symptoms, exam, and tests on blood, sputum, tissue, or other body fluids. Imaging such as a chest X-ray or CT scan, plus lab cultures or biopsy, may confirm the diagnosis of primary systemic mycosis.
Treatment and drugs
Treatment for Primary systemic mycosis usually centers on antifungal medicine, often for weeks to months. More severe illness may need hospital care with intravenous amphotericin B, then tablets such as itraconazole or fluconazole. Follow-up helps track recovery and side effects.
Symptoms
Primary systemic mycosis often begins with flu-like or chest symptoms after fungal spores are breathed in, but some people feel little at first. The early symptoms of primary systemic mycosis can be easy to mistake for a lingering cold, bronchitis, or pneumonia. If the infection becomes more severe or spreads beyond the lungs, it can also affect the skin, bones, or nervous system. Symptoms vary from person to person and can change over time.
Fever is common and may come with chills, sweating, or feeling generally unwell. Some people notice these symptoms come and go rather than staying constant.
A dry or mucus-producing cough is one of the most common symptoms when the lungs are involved. For many people with primary systemic mycosis, the cough can linger for days or weeks.
Breathing may feel tight or uncomfortable, especially with a deep breath or a coughing spell. Some may also have chest pain that feels similar to a chest infection.
Everyday activities such as climbing stairs or walking quickly may leave you more winded than usual. This can range from mild breathlessness to serious trouble breathing in severe infection.
How people usually first notice Primary systemic mycosis?
Primary systemic mycosis often begins quietly, like a lung infection that does not clear the way you would expect, and many people first notice fever, tiredness, cough, chest discomfort, or shortness of breath after breathing in fungal spores from the environment. Some also develop weight loss, night sweats, or skin changes, and in more severe cases the infection can spread beyond the lungs and cause headaches, confusion, bone pain, or swollen lymph nodes. Because these early symptoms can look like the flu, pneumonia, or tuberculosis, people with primary systemic mycosis are often first noticed when symptoms last longer than expected, keep getting worse, or do not improve with usual treatment.
Types of Primary systemic mycosis
Primary systemic mycosis is not just one illness pattern. The main types of primary systemic mycosis are usually defined by the fungus causing the infection, and each can affect the lungs first but differ in how often they spread and what symptoms stand out. Symptoms don’t always look the same for everyone. Some people feel like they have a mild flu, while others develop a longer-lasting cough, skin changes, or symptoms in other parts of the body.
Histoplasmosis
This type often starts with fever, tiredness, chest discomfort, and a dry cough after breathing in fungal spores. Many people have mild symptoms or none at all, but some develop more serious lung disease or spread of infection to places like the liver, spleen, or bone marrow.
Blastomycosis
This type commonly causes fever, cough, shortness of breath, and lung symptoms that can look like pneumonia. It is also more likely than some other forms to cause skin sores or lumps, and some may have bone or joint pain if it spreads.
Coccidioidomycosis
Often called valley fever, this type may cause fever, cough, headache, chest pain, and marked fatigue. Some people also develop a rash or joint aches, while a smaller number go on to have infection in the skin, bones, or brain lining.
Paracoccidioidomycosis
This type is more common in parts of Latin America and often develops slowly rather than all at once. People may notice weight loss, cough, swollen lymph nodes, and painful sores in the mouth or nose, which can make eating uncomfortable.
Talaromycosis
This type is seen mainly in parts of Asia and is more likely in people with weakened immune systems. It often causes fever, weight loss, cough, anemia, and a widespread rash or skin bumps, with infection that can involve several organs.
Can I slow down the onset of symptoms?
Usually no; there is no strong evidence that lifestyle changes can meaningfully delay the start of symptoms in primary systemic mycosis, which is a serious fungal infection that can spread through the body. The best-supported steps are to lower exposure in places where these fungi live, such as dusty soil or areas with bat or bird droppings, and to protect immune health, since this may reduce the chance of infection or severe illness but does not reliably prevent symptoms once infection happens. In some people with a weakened immune system, doctors may use early testing or preventive antifungal medicine in special high-risk situations, and getting checked early is sensible even though it cannot guarantee a different outcome.
What genetics can tell you about symptoms
For primary systemic mycosis, genetics usually cannot predict a specific set of symptoms in the way they can for inherited conditions. In most people, symptoms depend more on which fungus is involved, how much of it was inhaled, and the person’s overall health, although rare inherited differences in immune system genes can make some people more likely to develop earlier, more severe, or more widespread infection. Even then, genetic testing is not routinely used to forecast day-to-day symptoms, and it is only considered in unusual cases where repeated or severe fungal infections suggest an underlying immune problem.
Causes and risk factors
Primary systemic mycosis usually starts after you breathe in fungal spores from soil, dust, or places with bird or bat droppings. Living in or traveling to areas where these fungi are common, or doing work like farming, construction, landscaping, or caving, can raise exposure. Risk factors for primary systemic mycosis include a weakened immune system, chronic lung disease, older age, and in some cases inherited immune-system differences. Not everyone with the same risk develops the condition. Smoking and repeated dust exposure can add to risk, but many healthy people who inhale spores never become seriously ill.
What are the most common causes or risk factors?
Primary systemic mycosis is most often caused by breathing in fungal spores from the environment, especially in certain regions and after contact with disturbed soil, dust, or places with bird or bat droppings; work and hobbies such as farming, construction, gardening, and cave exploring can raise the risk. The main risk factors for more serious illness are a weakened immune system, older age or very young age, pregnancy for some of these infections, and long-term health problems. Less often, inherited immune system problems can also make some people more likely to get these infections or become more severely ill.
Environmental and biological risk factors
Primary systemic mycosis usually begins after someone breathes in tiny fungal spores from the air, often without realizing it. Doctors often group risks into internal (biological) and external (environmental). Understanding the main risk factors for primary systemic mycosis can help explain why some people get sick after an exposure while others stay well.
Primary systemic mycosis is more likely in places where these fungi naturally live in soil. Risk goes up if you live in, work in, or travel through those areas, and the exact locations depend on the fungus involved.
Digging, construction, farming, landscaping, and excavation can send fungal spores into the air. Breathing in that dust raises the chance of infection.
Soil or dust mixed with bird or bat droppings can carry large numbers of spores. This can happen in caves, attics, old buildings, bridges, and chicken coops.
Some jobs bring repeated exposure to soil, dust, woodlands, or decaying plant matter. Construction workers, farmers, forestry crews, archaeologists, and disaster-response teams may face higher risk.
Genetic risk factors
Primary systemic mycosis is not usually traced to one single inherited cause. In people who develop unusually severe, repeated, or widespread infection, doctors may look for genetic risk factors for primary systemic mycosis that affect how immune cells recognize fungi and send alarm signals. Carrying a genetic change doesn’t guarantee the condition will appear.
Immune signal defects: Rare inherited changes in the IL-12 and interferon-γ pathways can weaken the immune messages that help white blood cells control fungi. These are among the clearest genetic causes of unusually severe or widespread primary systemic mycosis.
GATA2 deficiency: GATA2 deficiency is a rare inherited condition that can lower or impair certain white blood cells. People with this disorder may have a higher risk of serious fungal infections.
T-cell disorders: Some inherited immune disorders weaken T-cell defenses, which are important for keeping fungal infections contained. When these defenses are low, primary systemic mycosis can be more severe or involve more than one part of the body.
Other immune genes: Rare changes in other immune genes involved in fungal sensing or white blood cell development may also raise risk. The exact gene can differ from one family to another, so genetic testing is usually tailored to the infection history and immune findings.
Family history: A family history of severe, repeated, or early fungal infections can be an important clue to inherited risk. This is especially helpful when close relatives had unusual infections at a young age.
Lifestyle risk factors
Lifestyle habits do not usually cause primary systemic mycosis on their own, but they can affect how vulnerable a person is to infection and how severe illness becomes. In practice, how lifestyle affects primary systemic mycosis often comes down to behaviors that weaken immune defenses, reduce lung health, or delay treatment. Diet, exercise, sleep, and substance use matter most through their effects on the body’s ability to contain and recover from fungal infection.
Undereating, protein deficiency, or a very low-quality diet can weaken immune function and make it harder for the body to control invasive fungal infection. Poor nutritional status may also slow recovery and worsen fatigue, weight loss, or general physical decline during illness.
Excess alcohol can impair immune responses and reduce the body’s ability to fight serious fungal infections. It may also contribute to poor nutrition, dehydration, and reduced adherence to medical care, which can worsen outcomes.
Smoking damages airway defenses and lung tissue, which can make it easier for inhaled fungi to establish infection and can aggravate respiratory symptoms. In people with pulmonary involvement, smoking may increase cough, shortness of breath, and the risk of complications.
Misuse of injected or other non-prescribed drugs can disrupt overall health, nutrition, and immune function, making severe infection harder to control. It can also delay care-seeking and interfere with consistent treatment, which is important in primary systemic mycosis.
Risk prevention
Primary systemic mycosis usually comes from breathing in fungal spores in certain outdoor environments, especially in regions where these fungi are more common. You cannot prevent every exposure, but you can lower your risk with practical steps at work, during travel, and around disturbed soil or dust. Prevention is about lowering risk, not eliminating it completely. This matters most for people with weakened immune systems, lung disease, or frequent exposure to dusty settings.
Try to avoid activities that stir up a lot of dust, such as digging, demolition, cave exploration, or handling dry soil in areas where these fungi live. Risk goes up when spores become airborne and are easy to breathe in.
If you cannot avoid heavy dust, wear a well-fitted respirator such as an N95 or similar mask rather than a loose face covering. This can lower the number of spores you breathe in, especially during outdoor work or cleanup.
People with jobs in farming, construction, landscaping, archaeology, or animal enclosure cleaning may need extra protection. Wetting soil before digging, improving ventilation, and using protective equipment can all reduce exposure.
If you are traveling to an area where these fungal infections are more common, be cautious around dusty roads, excavation sites, caves, and bird or bat droppings. Knowing your risks can guide which preventive steps matter most.
Can you prevent Primary systemic mycosis?
Primary systemic mycosis usually cannot be fully prevented, because the fungi that cause it live naturally in soil and dust in some areas. Risk may be lowered by avoiding activities that stir up a lot of dust or disturbed soil in places where these infections are common, and by using good breathing protection if that kind of exposure cannot be avoided. For people with a weakened immune system, working with a doctor to lower infection risk can also help, but it cannot guarantee prevention.
Transmission
Primary systemic mycosis is usually picked up from the environment, not from another person. Many people wondering how primary systemic mycosis is spread should know that these fungal infections most often begin after breathing in tiny fungal spores from soil or dust, sometimes in places contaminated by bird or bat droppings.
For everyday contact, primary systemic mycosis is generally not considered contagious, so hugging, sharing food, coughing near someone, or touching surfaces does not usually pass it on. Rare exceptions have been reported, such as through an infected transplanted organ or accidental laboratory exposure, but person-to-person spread is not the usual route.
When to test your genes
For primary systemic mycosis, genetic testing is not part of routine early detection. It may be worth discussing if someone has unusually severe, recurrent, or hard-to-treat fungal infections, especially starting young or with a family history, because inherited immune-system differences can sometimes shape risk and guide care.
Diagnosis
For many, the first step comes when everyday activities start feeling harder, such as a cough that does not settle, fever, weight loss, or unusual tiredness. Because primary systemic mycosis can affect the lungs first and then spread, doctors diagnose it by combining symptoms, travel or exposure history, an exam, and targeted tests. The diagnosis of primary systemic mycosis may take time because early symptoms can look like other infections or inflammatory illnesses.
Doctors usually begin by asking about symptoms, where you live or have traveled, and possible exposure to soil, dust, bird or bat droppings, or outdoor work. This helps them judge whether a fungal infection is likely and which fungi are more likely causes.
A clinician checks for signs such as fever, swollen lymph nodes, skin changes, breathing problems, or tenderness in affected areas. The exam can also show whether the illness seems limited to the lungs or may have spread elsewhere.
Blood work may look for signs of infection or inflammation and check how well organs such as the liver and kidneys are working. These tests do not confirm primary systemic mycosis on their own, but they help guide treatment and rule out common conditions.
Chest X-rays or CT scans can show lung nodules, patches of inflammation, enlarged lymph nodes, or other imaging findings linked to fungal infection. If symptoms suggest spread beyond the lungs, imaging of other body areas may also be needed.
How is Primary systemic mycosis diagnosed?
Primary systemic mycosis is usually diagnosed using a mix of symptoms, a doctor’s exam, and clues from where someone has lived, traveled, or been exposed to things like soil, dust, or bird or bat droppings. Doctors often use chest imaging, such as an X-ray or CT scan, along with lab tests on blood, mucus, or a small tissue sample to look for the fungus or signs that the body is reacting to it. Genetic testing of the person is not usually part of diagnosis, although some labs may use DNA-based tests on the germ itself to help tell exactly which fungus is causing the infection.
Stages of Primary systemic mycosis
Primary systemic mycosis does not have defined progression stages. This is because these fungal infections are usually described by where the infection is in the body, how severe it is, and how well someone responds to treatment, rather than by a fixed step-by-step pattern over time. Often the process begins when you notice changes in daily life, such as a fever that does not settle, a cough that lingers, weight loss, or unusual tiredness; the early symptoms of primary systemic mycosis can look like other common illnesses at first. Doctors usually diagnose and monitor it using a mix of symptoms, a physical exam, imaging such as chest scans, and lab tests on blood, sputum, or tissue samples to confirm the fungus and track whether treatment is working.
Outlook and prognosis
Outlook for primary systemic mycosis varies widely with the specific fungus involved, how extensive the infection is, and whether the person is immunocompromised, but many patients do well when the disease is recognized early and treated appropriately with antifungal therapy. Mild to moderate illness can often resolve with treatment, although recovery may take weeks to months and fatigue or lung symptoms can persist for some time. Prognosis is less favorable when infection has spread beyond the lungs to the brain, bones, skin, or other organs, or when diagnosis is delayed. Mortality is generally low in promptly treated, localized disease, but it can be substantial in severe disseminated infection, especially in infants, older adults, and people with HIV, transplants, cancer, or other causes of weakened immunity. Some forms can relapse, so follow-up is important even after symptoms improve. Overall, early diagnosis, appropriate antifungal choice, and careful monitoring are the main factors linked to a better long-term outcome.
Long-term effects
Primary systemic mycosis can have a very different long-term outlook depending on which fungus is involved, how early treatment starts, and whether the immune system is weakened. Many people recover fully, but others may have lingering organ problems, repeated flare-ups, or a long course of treatment. Thinking about the long-term effects helps set expectations, especially when early symptoms of primary systemic mycosis were vague and diagnosis came later. In severe cases, the infection can be life-threatening, particularly if it spreads widely through the body.
The lungs are often affected most, and some people are left with ongoing cough, shortness of breath, or lower exercise tolerance. Scarring or small nodules can remain even after the infection is treated.
Many living with primary systemic mycosis feel weak or worn down for weeks to months after the main infection improves. This can make work, exercise, and daily routines harder than usual.
If the infection reaches the brain, bones, skin, or other organs, long-term problems can depend on where it settled. Some may have lasting pain, nerve-related symptoms, or organ-specific damage even after treatment.
Some fungal infections can come back, especially in people with weakened immune systems. Doctors may track these changes over years to see whether treatment needs to continue or restart.
How is it to live with Primary systemic mycosis?
Living with primary systemic mycosis can feel exhausting and unpredictable, because symptoms such as fever, cough, chest discomfort, fatigue, weight loss, or shortness of breath may make work, exercise, sleep, and ordinary routines much harder. Many people need weeks to months of follow-up, antifungal treatment, and a slower pace while the body recovers, and if the infection becomes severe or spreads beyond the lungs, daily life can be much more limited. For loved ones, the biggest impact is often practical and emotional, helping with appointments, meals, and rest, while also understanding that most of these fungal infections are picked up from the environment rather than spread from person to person.
Treatment and drugs
Treatment for primary systemic mycosis usually centers on antifungal medicine, because the goal is to clear the fungus from the lungs and any other parts of the body it has reached. Mild illness may be treated with an oral antifungal taken for weeks to months, while severe primary systemic mycosis often needs hospital care and a stronger antifungal given into a vein, especially if breathing is affected or the infection has spread. Treatment plans often combine several approaches, including rest, fluids, pain or fever relief, and close follow-up to check that symptoms are improving and to watch for medicine side effects. In people with weakened immune systems, treatment may last longer, and doctors may adjust the plan based on the exact fungus, how serious the infection is, and how well the body is responding.
Can you cure Primary systemic mycosis?
Sometimes. Many people with primary systemic mycosis, a serious fungal infection that can spread through the body, can be cured with antifungal medicine, especially when it is found early and the immune system is working well. If the infection is severe or the immune system is weak, treatment may need to last for months and is aimed at clearing the infection, easing symptoms, and lowering the chance it comes back.
Non-drug treatment
Living with primary systemic mycosis can mean weeks or months of fatigue, cough, shortness of breath, weight loss, or trouble getting back to normal daily activities. Alongside medicines, non-drug therapies can help ease symptoms, support recovery, and manage complications while the infection is being treated. The best plan depends on which organs are involved and how sick someone is, so not every approach is needed for everyone. For many, this can be especially important during early symptoms of primary systemic mycosis, when rest, hydration, and close follow-up may help prevent problems from building.
Extra rest gives your body more energy to recover, especially when fever, cough, or exhaustion make normal routines hard. Drinking enough fluids can help prevent dehydration and may make mucus easier to clear.
Poor appetite and weight loss are common with primary systemic mycosis, so regular meals, snacks, and protein-rich foods can help maintain strength. If eating is difficult, a dietitian may suggest simple ways to add calories and fluids without making meals feel overwhelming.
People with primary systemic mycosis that affects the lungs may need oxygen therapy if blood oxygen levels drop. Breathing exercises, positioning, and airway-clearing techniques can sometimes make it easier to manage cough and shortness of breath.
Structured programs, like pulmonary rehabilitation, can help rebuild stamina after a severe lung infection. These programs usually combine supervised exercise, breathing training, and education so daily tasks feel less draining.
Your genes may have an impact on how drugs work for you
For most people with primary systemic mycosis, the main things that shape treatment are which fungus is causing the illness, how serious the infection is, and how well the liver and kidneys are working, rather than inherited differences in genes. Even so, small inherited differences can change how the body handles some antifungal medicines, so one person may need a different dose or closer checks for side effects while another does well on the usual plan. This kind of gene-based medicine matching, called pharmacogenomics, is not yet a routine part of care for primary systemic mycosis, but it can matter in some situations.
Pharmacological treatments
Treatment for primary systemic mycosis depends on which fungus is causing the infection, how severe it is, and which organs are involved. Many people with primary systemic mycosis do well with an oral antifungal, while severe illness often needs treatment started in the hospital. Not everyone responds to the same medication in the same way. In practice, doctors often begin with a stronger drug for urgent disease and then switch to a safer long-term medicine as things improve.
Itraconazole is a common first-choice oral treatment for many mild to moderate forms of primary systemic mycosis, especially when the lungs, skin, or bones are involved. It is often continued for months because these infections can clear slowly. Blood tests may be used to check drug levels and liver safety during treatment.
Amphotericin B is usually used for severe primary systemic mycosis, widespread infection, or illness affecting the brain, and it is often given by vein in the hospital. It works quickly and is a key option when someone is very unwell. Doctors watch kidney function, potassium, and magnesium closely during treatment.
Fluconazole is used in some types of primary systemic mycosis, especially when the infection involves the brain lining or when a long oral treatment is needed. It is also sometimes chosen when itraconazole is not a good fit. For some people, early symptoms of primary systemic mycosis improve only gradually even after treatment starts.
Voriconazole may be used when standard treatment is not working well or when the fungus is in places that are harder to treat, such as the central nervous system. It can be effective, but it may also cause vision changes, sun sensitivity, or liver test abnormalities. Drug interactions are common, so medication review is important.
Genetic influences
Most people who develop primary systemic mycosis become ill because they were exposed to fungal spores in the environment, not because they inherited a single disease gene. Still, genetics is only one piece of the puzzle, but it can help explain why one person has a mild illness while another develops severe primary systemic mycosis after a similar exposure. Rare inherited differences in the immune system, especially in pathways that help the body control fungal infections, can raise the risk of infection spreading beyond the lungs or becoming unusually serious. For many living with primary systemic mycosis, this means genes are more likely to affect how the body handles the infection than whether exposure happens in the first place. A strong family pattern is uncommon, but doctors may think about inherited immune problems if primary systemic mycosis happens in childhood, keeps coming back, or is much more severe than expected.
Is Primary systemic mycosis genetic?
Genetics usually play only a small part in primary systemic mycosis. Some inherited immune-system differences may raise susceptibility or affect how severe primary systemic mycosis becomes, but exposure and overall immune health are usually more important.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of being human, and they are widespread in the general population. Most of these variants do not have a direct effect on health and are simply part of normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
When treatment for primary systemic mycosis seems either too harsh or not strong enough, part of the reason can be how your body handles an antifungal medicine. Genes can influence how quickly you break down certain drugs, which may change how well they work or how likely they are to cause side effects. One of the clearest examples is voriconazole: some people have CYP2C19 gene variants that make them process it too slowly, raising the risk of problems such as liver irritation or visual side effects, while others clear it faster and may not get enough benefit. Not every difference in response is genetic, but your age, liver health, and other medicines also play a big part. For many living with primary systemic mycosis, this helps explain why treatment for primary systemic mycosis may work differently from person to person, even when the diagnosis is the same. Genetic testing is not used for every antifungal treatment, but in some situations it can help doctors choose a safer dose, monitor drug levels more closely, or consider a different medicine.
Interactions with other conditions
Primary systemic mycosis can be harder to recognize when it appears alongside common problems like pneumonia, tuberculosis, or even lung cancer, because the symptoms may look very similar at first. Many living with primary systemic mycosis also have another condition that changes how severe it becomes, especially illnesses that weaken the immune system such as HIV infection, blood cancers, or diabetes. Doctors call it a comorbidity when two conditions occur together. In these settings, the fungus is more likely to spread beyond the lungs and affect areas such as the skin, bones, brain, or other organs, so the early symptoms of primary systemic mycosis may seem vague but need prompt attention. Long-term lung diseases like COPD or severe asthma can also make cough, chest pain, and shortness of breath more disruptive in daily life, and they may blur the picture when doctors are trying to sort out the cause. Because some antifungal medicines can be harder to use safely in people with liver or kidney disease, it is important for the full health picture to be considered when planning care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Primary systemic mycosis?
Primary systemic mycosis can look a lot like other illnesses that cause fever, cough, chest pain, tiredness, and weight loss. It is most often confused with bacterial or viral pneumonia, tuberculosis, the flu or COVID-19, and sometimes lung cancer or sarcoidosis, a condition that causes swelling in the lungs and other parts of the body.
History
Throughout history, people have described severe fungal illnesses that did more than affect the skin or lungs alone. What we now group under primary systemic mycosis was often recognized only after people became very unwell, with fever, weight loss, cough, or sores that did not heal as expected. In day-to-day life, this could mean someone who seemed to have a lingering chest infection, then gradually developed problems in other parts of the body as well.
Early doctors usually understood these infections through what they could see during illness or after death, so the first descriptions were based on symptoms and damaged organs rather than on the exact fungus involved. Because the signs could look like tuberculosis, cancer, or other infections, many living with primary systemic mycosis were likely misdiagnosed at first. Not every early description was complete, yet together they helped doctors notice that some fungal infections could spread through the body instead of staying in one place.
As medical science evolved, microscopes, tissue staining, and laboratory culture made it easier to tell one fungal disease from another. Over time, researchers learned that several fungi found in soil and the environment could cause primary systemic mycosis, especially after spores were breathed in. This helped explain why outbreaks sometimes appeared in certain regions, jobs, or travel settings, and why early symptoms of primary systemic mycosis could start like a routine flu-like illness before becoming more serious.
In recent decades, better imaging, blood tests, and fungal testing have improved recognition of primary systemic mycosis. Doctors also came to understand that illness can range from mild to life-threatening, depending on the type of fungus, how much exposure occurred, and a person’s overall health and immune function. Knowing this history helps explain why diagnosis can still take time today, but also why treatment and outcomes have improved so much compared with the past.